Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long NVO ETF

12.61
+0.22001.78%
Pre-market: 12.39-0.2200-1.74%07:25 EDT
Volume:175.77K
Turnover:2.21M
Market Cap:33.01M
PE:- -
High:12.74
Open:12.68
Low:12.40
Close:12.39
52wk High:36.00
52wk Low:9.23
Shares:2.62M
Float Shares:2.62M
Volume Ratio:0.54
T/O Rate:6.71%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo-Nordisk CEO Defends Wegovy Oral Pill Amid Pricing Pressure, Shares Slide on Sales Concern

Deep News
·
Aug 05

European Stocks Extend Record Highs

Dow Jones
·
Aug 05

Novo Nordisk Shares Likely to Fall at Open, but Less than in U.S. Session

Dow Jones
·
Aug 05

Novo Nordisk A/S Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Novo Nordisk Earnings Beat but Study Data, Wegovy Pill Sales Underwhelm

Dow Jones
·
Aug 05

Dow Jones Top Company Headlines at 7 PM ET: SpaceX Revenue Could Reach $1 Trillion, Elon Musk Says | Paramount's ...

Dow Jones
·
Aug 05

Novo Nordisk Q2 Adj. EPS $0.96 Beats $0.81 Estimate, Sales $12.209B Beat $11.350B Estimate

Benzinga Earnings
·
Aug 05

NYSE Most Active Issues

Dow Jones
·
Aug 05

The Wegovy Pill's 'surprise Miss' is One Reason Novo Nordisk's Stock is Down

Dow Jones
·
Aug 05

Wegovy Maker Novo Nordisk Lifts Annual Forecast Amid Rising Demand for Weight-Loss Drugs

Deep News
·
Aug 05

Novo Nordisk Raises Earnings Guidance. the Stock Sinks.

Dow Jones
·
Aug 05

Wegovy-Maker Novo Nordisk Raises Full-Year Guidance as Appetite for Weight-Loss Drugs Grows

Dow Jones
·
Aug 05

Novo Nordisk Lifts 2026 Outlook After Strong Q2 Adjusted Results

TIPRANKS
·
Aug 05

Novo Nordisk Q2 Lifts FY Guidance on Stronger GLP-1 Demand

Reuters
·
Aug 05

Novo Nordisk Boosts Adjusted Sales, Operating Profit Guidance for 2026

MT Newswires Live
·
Aug 05

Novo Nordisk reports Q2 adjusted sales DKK 78.49B, up 7% at CER

TIPRANKS
·
Aug 05

Novo Nordisk raises FY26 adjusted sales view to 0% to down 6% from down 4%-12%

TIPRANKS
·
Aug 05

Novo Nordisk Probes Thyroid Cancer Risk in Real‑World GLP‑1 Users

TIPRANKS
·
Aug 05

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

TIPRANKS
·
Aug 04

Legal Inquiry Launched for Hims & Hers Health Following Share Plunge

Deep News
·
Aug 04